Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group-Reference-Cited by-同舟云学术

Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group

Published:2010-06 Issue:3 Volume:10 Page:230-237
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Gogas Helen,Pectasides Dimitrios,Kostopoulos Ioannis,Lianos Evangelos,Skarlos Dimosthenis,Papaxoinis George,Bobos Mattheos,Kalofonos Haralabos P.,Petraki Kalliopi,Pavlakis Kitty,Bafaloukos Dimitrios,Fountzilas George

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Preoperative chemotherapy treatment of breast cancer—a review;Buzdar;Cancer,2007

2. First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group;Fountzilas;Ann Oncol,1998

3. A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma;Perez;Cancer,2000

4. Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group;Fountzilas;Ann Oncol,2004

5. A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study;Fountzilas;Breast Cancer Res Treat,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer;Journal of Oncology;2022-11-28

2. Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis;Experimental and Therapeutic Medicine;2021-11-26

3. Salubrinal Exposes Anticancer Properties in Inflammatory Breast Cancer Cells by Manipulating the Endoplasmic Reticulum Stress Pathway;Frontiers in Oncology;2021-05-20

4. The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers;Scientific Reports;2021-02-04

5. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response;BMC Cancer;2019-06-17